UK stocks slumped on Monday as investors scurried to safer assets including gold following a sharp rise in coronavirus cases outside China, which stoked fears over a possible pandemic that would impact on global growth. At 16.35 p.m. the benchmark FTSE 100 index was down 247.09 points, or 3.34%, at 7,156.83. LARGE AND MID CAP RISERS AND FALLERS Associated British Foods softened 1.7% to £25.40 after the owner of the Primark budget clothing chain said the coronavirus outbreak could cause shortages in its supply chain. Daily Mirror and Daily Express newspaper publisher Reach rose 3.1% to 180p after swinging to a full year profit as cost cutting offset falling sales. Reach also said it was targeting a rise to 7m registered customers by the end of 2022, up from less than 1m at the end of 2019, as part of a strategy update. Outsourcing company Bunzl gained 2.5% to trade at £19.98, having reported a rise in annual profit even as revenue was held back by a weaker performance in North America. Veterinary pharmaceuticals company Dechra Pharmaceuticals shed 0.9% to trade at £27.76, even as its half-yearly profit more than doubled. Dechra Pharmaceuticals also warned of supply challenges in its North America business. Research tool manufacturer Oxford Instruments slipped 4.7% to £15.34 after the company sold its OI Healthcare business in the US to MXR Imaging for $15.0m (£11.5m). Specialist information, data and analytics company Ascential ascended 4.1% to 368.6p after reporting annual results that showed strong growth in sales and adjusted profit and announcing a £120m share buyback programme. SMALL CAP RISERS AND FALLERS Infection prevention product manufacturer Tristel ticked 10.8% higher to 437.5p as it posted a 25% rise in first-half profit that it said exceeded its expectations. Tristel also said the coronavirus outbreak would be a 'powerful influence' for greater global investment in infection prevention and control. Vehicle telematics services provider Quartix fell 1.8% to 427p, having booked a decline in annual profit owing to sales slumping in its insurance division. Cell-based therapeutics developer ReNeuron improved 4.9% to 149.5p on recording positive long-term data from a trial of a treatment for retinitis pigmentosa. Pesticides company Plant Health Care sank 35.4% to 9.2p as it launched a share issue to raise at least $4m, at 8p a share. Recruitment company RTC reversed 4% to 72.5p after it posted a 5.4% fall in annual profit as rising revenue was more than offset by higher expenses.
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.